evaluate novo nordisk on glp-1 agonists Competitive Environment GLP-1s Are Just Getting Started:

[40] With the knowledge of the dopaminergic stimulant effects of the adamantane derivatives, bromantane, which is 2-(4-bromophenylamino) adamantane, was developed in the 1980s at the Zakusov State Institute of Pharmacology, USSR Academy of Medical Sciences (now the Russian Academy of Medical Sciences) in Moscow as "a drug having psychoactivating and adaptogen properties under complicated conditions (hypoxia, high environmental temperature, physical overfatigue, emotional stress, etc.)"

10.1172/JCI26498 78 KandulaT.FarrarM

The confusion between different whitening treatments often leads to anxiety, worrying about side effects, costs, and whether the results will truly last

Because the follow-up time was fairly short, these results may have been caused by reverse causality, where a developing, undiagnosed condition was influencing IGF-1 levels at the time when the samples were taken

Namour F, Anderson K, Nelson C, Tasset C